{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:36:16Z","timestamp":1794278176660,"version":"4.9.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.molmet.2021.101428","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T12:12:44Z","timestamp":1640866364000},"page":"101428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":212,"special_numbering":"C","title":["CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing"],"prefix":"10.1016","volume":"57","author":[{"given":"Han","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enze","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong Z.","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.molmet.2021.101428_bib1","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.molmet.2021.101428_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2021.101428_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/med.21515","article-title":"Progress and challenges in the prevention and control of nonalcoholic fatty liver disease","volume":"39","author":"Cai","year":"2019","journal-title":"Medicinal Research Reviews"},{"issue":"5","key":"10.1016\/j.molmet.2021.101428_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.molmet.2021.101428_bib5","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101428_bib6","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Digestive Diseases and Sciences"},{"issue":"9","key":"10.1016\/j.molmet.2021.101428_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/nu9090981","article-title":"Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease","volume":"9","author":"ter Horst","year":"2017","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.molmet.2021.101428_bib8","first-page":"351","article-title":"Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"20","author":"Kohjima","year":"2007","journal-title":"International Journal of Molecular Medicine"},{"issue":"11","key":"10.1016\/j.molmet.2021.101428_bib9","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1172\/JCI94585","article-title":"Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling","volume":"127","author":"Softic","year":"2017","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/j.molmet.2021.101428_bib10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrneph.2017.126","article-title":"CD36 in chronic kidney disease: novel insights and therapeutic opportunities","volume":"13","author":"Yang","year":"2017","journal-title":"Nature Reviews Nephrology"},{"issue":"10","key":"10.1016\/j.molmet.2021.101428_bib11","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.molmet.2021.101428_bib12","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2337\/db07-0907","article-title":"Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity","volume":"56","author":"Koonen","year":"2007","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.molmet.2021.101428_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","article-title":"CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis","volume":"69","author":"Zhao","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101428_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ijo.2016.223","article-title":"Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls","volume":"41","author":"Heeboll","year":"2017","journal-title":"International Journal of Obesity"},{"issue":"4","key":"10.1016\/j.molmet.2021.101428_bib15","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1096\/fj.201902777RR","article-title":"Loss of CD36 impairs hepatic insulin signaling by enhancing the interaction of PTP1B with IR","volume":"34","author":"Yang","year":"2020","journal-title":"The FASEB Journal"},{"issue":"4","key":"10.1016\/j.molmet.2021.101428_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/ars.2016.6808","article-title":"Cluster of differentiation 36 deficiency aggravates macrophage infiltration and hepatic inflammation by upregulating monocyte chemotactic protein-1 expression of hepatocytes through histone deacetylase 2-dependent pathway","volume":"27","author":"Zhong","year":"2017","journal-title":"Antioxidants and Redox Signaling"},{"issue":"11","key":"10.1016\/j.molmet.2021.101428_bib17","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1194\/jlr.M037812","article-title":"CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob\/ob mice","volume":"54","author":"Nassir","year":"2013","journal-title":"Journal of Lipid Research"},{"issue":"4","key":"10.1016\/j.molmet.2021.101428_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1050-1738(03)00026-4","article-title":"Pathophysiology of human genetic CD36 deficiency","volume":"13","author":"Hirano","year":"2003","journal-title":"Trends in Cardiovascular Medicine"},{"issue":"9","key":"10.1016\/j.molmet.2021.101428_bib19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1046\/j.1537-2995.2002.00176.x","article-title":"Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature","volume":"42","author":"Curtis","year":"2002","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.molmet.2021.101428_bib20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1537-2995.1999.39080873.x","article-title":"CD36 deficiency is frequent and can cause platelet immunization in Africans","volume":"39","author":"Lee","year":"1999","journal-title":"Transfusion"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2021.101428_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11010-005-9031-4","article-title":"Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients","volume":"299","author":"Yamashita","year":"2007","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"10","key":"10.1016\/j.molmet.2021.101428_bib22","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1172\/JCI99315","article-title":"Endothelial cell CD36 optimizes tissue fatty acid uptake","volume":"128","author":"Son","year":"2018","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.molmet.2021.101428_bib23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2015-1866","article-title":"Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice","volume":"157","author":"Wilson","year":"2016","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101428_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2337\/db14-0582","article-title":"Regulation of AMPK activaticin by CD36 links fatty acid uptake to beta-oxidation","volume":"64","author":"Samovski","year":"2015","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.molmet.2021.101428_bib25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1194\/jlr.M090969","article-title":"CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway[S]","volume":"60","author":"Li","year":"2019","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.molmet.2021.101428_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102849","article-title":"Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans","volume":"57","author":"Bai","year":"2020","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.molmet.2021.101428_bib27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nature Reviews Endocrinology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101428_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3803\/EnM.2017.32.1.6","article-title":"The SCAP\/SREBP pathway: a mediator of hepatic steatosis","volume":"32","author":"Moon","year":"2017","journal-title":"Endocrinology and Metabolism"},{"issue":"50","key":"10.1016\/j.molmet.2021.101428_bib29","doi-asserted-by":"crossref","first-page":"52772","DOI":"10.1074\/jbc.M410302200","article-title":"Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and insigs","volume":"279","author":"Adams","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"20","key":"10.1016\/j.molmet.2021.101428_bib30","doi-asserted-by":"crossref","first-page":"11235","DOI":"10.1073\/pnas.96.20.11235","article-title":"Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi","volume":"96","author":"Nohturfft","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.molmet.2021.101428_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jb\/mvu019","article-title":"A\u00a0novel processing system of sterol regulatory element-binding protein-1c regulated by polyunsaturated fatty acid","volume":"155","author":"Nakakuki","year":"2014","journal-title":"Journal of Biochemistry"},{"issue":"11","key":"10.1016\/j.molmet.2021.101428_bib32","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1073\/pnas.95.11.5987","article-title":"Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice","volume":"95","author":"Horton","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"5","key":"10.1016\/j.molmet.2021.101428_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccell.2015.09.021","article-title":"Glucose-mediated N-glycosylation of SCAP is essential for SREBP-1 activation and tumor growth","volume":"28","author":"Cheng","year":"2015","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.molmet.2021.101428_bib34","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1093\/jn\/132.11.3333","article-title":"Dietary polyunsaturated fats regulate rat liver sterol regulatory element binding proteins-1 and-2 in three distinct stages and by different mechanisms","volume":"132","author":"Xu","year":"2002","journal-title":"Journal of Nutrition"},{"issue":"6","key":"10.1016\/j.molmet.2021.101428_bib35","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1074\/jbc.M007273200","article-title":"Unsaturated fatty acids down-regulate SREBP isoforms 1a and 1c by two mechanisms in HEK-293 cells","volume":"276","author":"Hannah","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.molmet.2021.101428_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2004.11.043","article-title":"Hyperlipidemic effects of dietary saturated fats mediated through PGC-1 beta cactivation of SREBP","volume":"120","author":"Lin","year":"2005","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.molmet.2021.101428_bib37","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100156","article-title":"Cideb controls sterol-regulated ER export of SREBP\/SCAP by promoting cargo loading at ER exit sites","volume":"38","author":"Su","year":"2019","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.molmet.2021.101428_bib38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1146\/annurev-biochem-062917-011852","article-title":"Retrospective on cholesterol homeostasis: the central role of scap","volume":"87 87","author":"Brown","year":"2018","journal-title":"Annual Review of Biochemistry"},{"issue":"40","key":"10.1016\/j.molmet.2021.101428_bib39","doi-asserted-by":"crossref","first-page":"31078","DOI":"10.1074\/jbc.M005353200","article-title":"Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene","volume":"275","author":"Amemiya-Kudo","year":"2000","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101428_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","article-title":"Protein sensors for membrane sterols","volume":"124","author":"Goldstein","year":"2006","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.molmet.2021.101428_bib41","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.7150\/thno.36037","article-title":"CD36 tango in cancer: signaling pathways and functions","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"issue":"28","key":"10.1016\/j.molmet.2021.101428_bib42","doi-asserted-by":"crossref","first-page":"26483","DOI":"10.1074\/jbc.M504041200","article-title":"Insig required for sterol-mediated inhibition of Scap\/SREBP binding to COPII proteins in\u00a0vitro","volume":"280","author":"Sun","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101428_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2010.12.004","article-title":"Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques","volume":"13","author":"Tang","year":"2011","journal-title":"Cell Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2021.101428_bib44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/diacare.26.2.471","article-title":"Insulin sensitivity and lipid metabolism in human CD36 deficiency","volume":"26","author":"Furuhashi","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.molmet.2021.101428_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tem.2008.11.001","article-title":"Cellular fatty acid uptake: a pathway under construction","volume":"20","author":"Su","year":"2009","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101428_bib46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physrev.00003.2009","article-title":"Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease","volume":"90","author":"Glatz","year":"2010","journal-title":"Physiological Reviews"},{"issue":"11","key":"10.1016\/j.molmet.2021.101428_bib47","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.2337\/db14-0369","article-title":"Free fatty acid uptake in humans with CD36 deficiency","volume":"63","author":"Hames","year":"2014","journal-title":"Diabetes"},{"issue":"27","key":"10.1016\/j.molmet.2021.101428_bib48","doi-asserted-by":"crossref","first-page":"19055","DOI":"10.1074\/jbc.274.27.19055","article-title":"A\u00a0null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism","volume":"274","author":"Febbraio","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.molmet.2021.101428_bib49","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1194\/jlr.M041863","article-title":"CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis","volume":"55","author":"Clugston","year":"2014","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.molmet.2021.101428_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08585-4","article-title":"Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene","volume":"10","author":"Han","year":"2019","journal-title":"Nature Communications"},{"issue":"7804","key":"10.1016\/j.molmet.2021.101428_bib51","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-020-2183-2","article-title":"The gluconeogenic enzyme PCK1 phosphorylates INSIG1\/2 for lipogenesis","volume":"580","author":"Xu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2021.101428_bib52","article-title":"Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis","volume":"6","author":"Wang","year":"2016","journal-title":"Scientific Reports"},{"issue":"11","key":"10.1016\/j.molmet.2021.101428_bib53","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.peptides.2010.07.020","article-title":"Insulin-induced gene A new regulator in lipid metabolism","volume":"31","author":"Dong","year":"2010","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.molmet.2021.101428_bib54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.mp.4002133","article-title":"Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?","volume":"14","author":"Le Hellard","year":"2009","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.molmet.2021.101428_bib55","article-title":"The CC genotype of insulin-induced gene 2 rs7566605 is a protective factor of hypercholesteremia susceptible to mild cognitive impairment, especially to the executive function of patients with type 2 diabetes mellitus","volume":"2020","author":"Zhang","year":"2020","journal-title":"BioMed Research International"},{"issue":"1","key":"10.1016\/j.molmet.2021.101428_bib56","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3945\/ajcn.2010.29422","article-title":"No association between polymorphisms in the INSIG1 gene and the risk of type 2 diabetes and related traits","volume":"92","author":"Szopa","year":"2010","journal-title":"American Journal of Clinical Nutrition"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821002866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821002866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:29:25Z","timestamp":1761956965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877821002866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":56,"alternative-id":["S2212877821002866"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101428","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101428"}}